The Assert-IQ Insertable Cardiac Monitor (ICM) by Abbott provides advanced monitoring capabilities for the detection and management of arrhythmias. Abbott’s Assert-IQ ICM, which comes in models DMS000, DM5300, and DM5500, is primarily used for patients with symptoms possibly related to cardiac issues, those at risk for abnormal cardiac rhythms, and individuals with a history or susceptibility to atrial fibrillation (AF).
Product Features
Key features of this device include a slim design for discreet and straightforward insertion. The Assert-IQ ICM boasts the longest-lasting battery life in its category, offering Bluetooth functionality without sacrificing features. This model differentiates itself with Advanced algorithms that significantly reduce the occurrence of false detections and maintain the accuracy of true event capture. Users also have access to Key Episode technology which allows clinicians to review all episodes or filter the most critical ones based on clinical or patient needs.
The quality of its Electrogram (EGM) readings provides superior P-wave visibility, potentially expediting clinical decisions. Furthermore, the Assert-IQ ICM’s Remote Programming feature allows adjustments to device settings remotely for optimized performance, enabling clinicians to limit unnecessary alerts and consequently reducing the need for in-person clinic visits.
Connectivity and Monitoring
Assert-IQ ICM links seamlessly with myMerlin™ Mobile App via Bluetooth, meaning no extra bedside transmitters or patient activators are required. The connection is persistent, checking in with the device every 20 seconds, ensuring timely encrypted data transmission to Merlin.net™ Patient Care Network (PCN). The ICM monitors cardiac rhythm consistently, while the mobile app automatically transmits data according to a predefined schedule and clinic-set alerts, which helps in adherence to remote monitoring protocols. Integrated activator functionality within the app also allows patients to capture and send EGMs during symptomatic periods. The app provides notifications to patients about daily checks and scheduled transmissions and is available in over 35 languages to cater to a diverse patient base.
Advanced Diagnostics
IQ Insights grants clinicians the ability to make prompt and well-informed decisions with added diagnostics such as the leading Premature Ventricular Contraction (PVC) detection algorithm. Added sensors assist in capturing consecutive events like couplets and triplets, and the device also tracks body position and posture during the event onset, which aids in a comprehensive episode assessment.
Product Specifications
The manual lists the product content, which includes the ICM device, an insertion tool, and an incision tool. The devices vary slightly in dimensions and weight but share a design ensuring a lifespan of several years.
Compatibility and Safety Information
Last but not least, the Assert-IQ ICM is confirmed to be MR Conditional at both 1.5 Tesla (T) and 3T, ensuring patients can undergo MRI scans with the device implanted under certain conditions.
References:
Download: Assert-IQ Insertable Cardiac Monitor User Manual
Chat: Powered By VoiceSphere